Homebiopharmaceutical

biopharmaceutical

Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis

Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis

December 31, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

December 30, 2020

Aeglea (AGLE) Upgraded to Buy: Here’s Why

Aeglea (AGLE) Upgraded to Buy: Here’s Why

December 30, 2020

Novo Nordisk (NVO) Files for Ozempic’s Label Expansion in EU

Novo Nordisk (NVO) Files for Ozempic’s Label Expansion in EU

December 30, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 30, 2020

New Strong Sell Stocks for December 30th

New Strong Sell Stocks for December 30th

December 30, 2020

Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) Digital 2021

Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) Digital 2021

December 30, 2020

Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor

Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor

December 29, 2020

Hepion Pharmaceuticals Announces Positive Top Line Data for Low Dose CRV431 in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH

Hepion Pharmaceuticals Announces Positive Top Line Data for Low Dose CRV431 in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH

December 29, 2020

Top NASDAQ Biotech Stocks of 2020

Top NASDAQ Biotech Stocks of 2020

December 29, 2020

« 1 … 536 537 538 539 540 … 558 »